Cargando…
Recent Advances in Pharmacotherapy Development for Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is a common disease causing segmental expansion and rupture of the aorta with a high mortality rate. The lack of nonsurgical treatment represents a large and unmet need in terms of pharmacotherapy. Advances in AAA research revealed that activation of inflammatory sign...
Autores principales: | Yoshimura, Koichi, Aoki, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432368/ https://www.ncbi.nlm.nih.gov/pubmed/22957259 http://dx.doi.org/10.1155/2012/648167 |
Ejemplares similares
Ejemplares similares
-
Development of pharmacotherapies for abdominal aortic aneurysms
por: Weaver, Lauren M., et al.
Publicado: (2022) -
Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms
por: Bumdelger, Batmunkh, et al.
Publicado: (2016) -
Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2022) -
Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A
Systematic Review and Meta-Analysis
por: Su, Zhixiang, et al.
Publicado: (2022) -
Towards Precritical Medical Therapy of the Abdominal Aortic Aneurysm
por: Musumeci, Lucia, et al.
Publicado: (2022)